| 摘要 |
<p>The present invention relates to a pharmaceutical composition comprising, as active substance, at least one hormone chosen among 3,5-diiodothyronine (3,5-T2), 3',3- diiodothyronine (3',3-T2), 3',5-diiodothyronine (3 ',5-T2), 3 '-iodothyronine (3'-T), 3- iodothyronine (3-T) or 5 -iodothyronine (5-T), in association with a pharmaceutically acceptable vehicle.</p> |
| 申请人 |
UNIVERSITE JOSEPH FOURIER;INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE SCIENTIFIQUE);CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE;LEVERVE, XAVIER;TALEUX, NELLIE;FAVIER, ROLAND |
发明人 |
LEVERVE, XAVIER;TALEUX, NELLIE;FAVIER, ROLAND |
